title: Understanding the role of NRF2-regulated miRNAs in human malignancies.
abstract: Nuclear factor (erythroid-derived 2)-like 2 (NRF2) is a key transcription factor that regulates the expression of over a hundred cytoprotective and antioxidant genes that provide cellular protection from reactive oxygen species. Chemotherapy resistance in several cancers has been linked to dysregulation of the NRF2 signalling pathway, moreover there is growing evidence that NRF2 may contribute to tumorigenesis. MicroRNA (miRNA) are small non-coding RNA sequences that post-transcriptionally regulate mRNA sequences. In cancer pathogenesis, aberrantly expressed miRNAs can act as either tumor suppressor or oncogenic miRNA. Recent evidence has been described that identifies a number of miRNA that can be regulated by NRF2. This review outlines the importance of NRF2 in regulating miRNA, and the functional role this may have in the tumorigenesis of human malignancies and their chemotherapy resistance.
authors.affiliation: Norwich Medical School, University of East Anglia, Norwich Research Park, Norwich, United Kingdom.
authors.forename: Niraj M
authors.initials: NM
authors.lastname: Shah
authors.forename: Stuart A
authors.initials: SA
authors.lastname: Rushworth
authors.forename: Megan Y
authors.initials: MY
authors.lastname: Murray
authors.forename: Kristian M
authors.initials: KM
authors.lastname: Bowles
authors.forename: David J
authors.initials: DJ
authors.lastname: MacEwan
mesh_terms: D006801:Humans; D035683:MicroRNAs / Q000235:genetics* / Q000378:metabolism; D051267:NF-E2-Related Factor 2 / Q000235:genetics* / Q000378:metabolism; D009369:Neoplasms / Q000235:genetics* / Q000378:metabolism; D015398:Signal Transduction
chemical_list: D035683:MicroRNAs; D051267:NF-E2-Related Factor 2; C495635:NFE2L2 protein, human
references.citation: Proc Natl Acad Sci U S A. 2010 Apr 6;107(14):6334-9
references.pmid: 20308559
references.citation: Nature. 2011 Jul 06;475(7354):106-9
references.pmid: 21734707
references.citation: Cancer Res. 2011 May 15;71(10):3552-62
references.pmid: 21444677
references.citation: J Exp Med. 2008 Oct 27;205(11):2499-506
references.pmid: 18936236
references.citation: Proc Natl Acad Sci U S A. 1996 Nov 26;93(24):13943-8
references.pmid: 8943040
references.citation: J Biol Chem. 2012 Mar 23;287(13):9873-9886
references.pmid: 22275372
references.citation: Cell Death Dis. 2012 Nov 29;3:e436
references.pmid: 23190608
references.citation: Proc Natl Acad Sci U S A. 2005 Sep 27;102(39):13944-9
references.pmid: 16166262
references.citation: Nat Rev Drug Discov. 2010 Oct;9(10):775-89
references.pmid: 20885409
references.citation: Proc Natl Acad Sci U S A. 2010 Apr 20;107(16):7479-84
references.pmid: 20368435
references.citation: Eur J Gastroenterol Hepatol. 2013 Aug;25(8):953-7
references.pmid: 23751352
references.citation: Carcinogenesis. 2012 Jan;33(1):220-5
references.pmid: 22072615
references.citation: Mol Cancer Res. 2010 Sep;8(9):1207-16
references.pmid: 20696752
references.citation: J Mol Neurosci. 2012 Feb;46(2):324-35
references.pmid: 21720722
references.citation: Oncogene. 2012 Oct 11;31(41):4460-71
references.pmid: 22266859
references.citation: Oncogene. 2009 Nov 5;28(44):3937-48
references.pmid: 19701247
references.citation: Virchows Arch. 2012 Apr;460(4):371-7
references.pmid: 22395483
references.citation: Cell Death Differ. 2012 Mar;19(3):378-86
references.pmid: 21979467
references.citation: Hepatology. 2009 Aug;50(2):472-80
references.pmid: 19585654
references.citation: BMC Mol Biol. 2012 Jan 31;13:4
references.pmid: 22292433
references.citation: Eur J Cancer. 2009 Aug;45(12):2219-27
references.pmid: 19524433
references.citation: Clin Cancer Res. 2011 May 1;17(9):3029-38
references.pmid: 21248297
references.citation: Nat Cell Biol. 2006 Mar;8(3):278-84
references.pmid: 16489342
references.citation: Breast Cancer Res Treat. 2011 Oct;129(3):983-91
references.pmid: 21638050
references.citation: Oncol Rep. 2012 May;27(5):1312-20
references.pmid: 22366961
references.citation: Biochem Biophys Res Commun. 2005 Sep 9;334(4):1351-8
references.pmid: 16039986
references.citation: Drug Metab Rev. 2006;38(4):769-89
references.pmid: 17145701
references.citation: Biochem Biophys Res Commun. 1997 Jul 18;236(2):313-22
references.pmid: 9240432
references.citation: Invest Ophthalmol Vis Sci. 2008 Apr;49(4):1671-8
references.pmid: 18385090
references.citation: Leuk Lymphoma. 2009 Nov;50(11):1865-71
references.pmid: 19883314
references.citation: Biochem Biophys Res Commun. 2013 Apr 5;433(2):207-12
references.pmid: 23466356
references.citation: Am J Pathol. 2012 Nov;181(5):1823-35
references.pmid: 22982443
references.citation: BMC Cancer. 2009 Nov 18;9:401
references.pmid: 19922656
references.citation: Cancer Genet. 2012 Nov;205(11):545-51
references.pmid: 23098991
references.citation: Carcinogenesis. 2010 May;31(5):777-84
references.pmid: 20080834
references.citation: Life Sci. 2012 Oct 5;91(11-12):440-447
references.pmid: 22963810
references.citation: Mol Cancer Ther. 2010 Aug;9(8):2365-76
references.pmid: 20682644
references.citation: J Clin Invest. 2013 Jul;123(7):2921-34
references.pmid: 23921124
references.citation: Cancer Res. 2013 Apr 1;73(7):2044-51
references.pmid: 23365135
references.citation: Clin Cancer Res. 2009 Sep 15;15(18):5744-52
references.pmid: 19737949
references.citation: Proc Natl Acad Sci U S A. 2010 Dec 14;107(50):21558-63
references.pmid: 21118985
references.citation: Proc Natl Acad Sci U S A. 1996 Dec 10;93(25):14960-5
references.pmid: 8962164
references.citation: Proc Natl Acad Sci U S A. 1994 Oct 11;91(21):9926-30
references.pmid: 7937919
references.citation: J Biol Chem. 2012 Sep 7;287(37):31503-14
references.pmid: 22493435
references.citation: Gastroenterology. 2006 Sep;131(3):830-40
references.pmid: 16952552
references.citation: Cancer Lett. 2013 May 10;332(1):94-101
references.pmid: 23348698
references.citation: EMBO Rep. 2008 Jun;9(6):582-9
references.pmid: 18483486
references.citation: Neoplasia. 2011 Sep;13(9):864-73
references.pmid: 21969819
references.citation: Science. 2004 Jan 2;303(5654):83-6
references.pmid: 14657504
references.citation: J Biol Chem. 2011 Mar 4;286(9):7629-40
references.pmid: 21196497
references.citation: Gastroenterology. 2007 Aug;133(2):647-58
references.pmid: 17681183
references.citation: J Cell Biol. 2011 Apr 18;193(2):275-84
references.pmid: 21482715
references.citation: Genes Chromosomes Cancer. 2009 Jul;48(7):615-23
references.pmid: 19396864
references.citation: Blood. 2010 Nov 18;116(20):4338-48
references.pmid: 20709907
references.citation: Nucleic Acids Res. 2012 Aug;40(15):7416-29
references.pmid: 22581777
references.citation: Mol Cell Biol. 2012 Feb;32(3):633-51
references.pmid: 22144583
references.citation: World J Gastroenterol. 2012 Oct 14;18(38):5442-53
references.pmid: 23082062
references.citation: Mol Cancer Ther. 2010 Feb;9(2):336-46
references.pmid: 20124447
references.citation: Free Radic Biol Med. 2008 Aug 15;45(4):537-46
references.pmid: 18539158
references.citation: Neurol Res. 2013 Jan;35(1):71-8
references.pmid: 23006842
references.citation: Oncotarget. 2011 Sep;2(9):658-68
references.pmid: 21911919
references.citation: J Biol Chem. 2003 Jun 13;278(24):21592-600
references.pmid: 12682069
references.citation: Mol Cancer Res. 2012 Apr;10(4):504-15
references.pmid: 22343615
references.citation: Cancer Res. 2011 Mar 1;71(5):1999-2009
references.pmid: 21212410
references.citation: Dig Liver Dis. 2006 Jul;38(7):490-7
references.pmid: 16627020
references.citation: Mol Cancer. 2010 Jun 28;9:169
references.pmid: 20579395
references.citation: J Oncol. 2010;2010:821717
references.pmid: 20049172
references.citation: J Cell Biochem. 2013 Mar;114(3):606-15
references.pmid: 22991189
references.citation: J Cell Biol. 2001 May 28;153(5):1023-34
references.pmid: 11381087
references.citation: Cancer Res. 2010 Apr 1;70(7):2973-83
references.pmid: 20332229
references.citation: Clin Cancer Res. 2013 May 1;19(9):2310-8
references.pmid: 23388504
references.citation: Cancer Res. 2008 Jan 15;68(2):537-44
references.pmid: 18199550
references.citation: Mol Cancer Ther. 2009 Aug;8(8):2432-40
references.pmid: 19638449
references.citation: Cell Cycle. 2012 Jun 15;11(12):2248-52
references.pmid: 22617388
references.citation: Oncol Rep. 2011 Oct;26(4):1011-7
references.pmid: 21743970
references.citation: Cancer Cell. 2011 Oct 18;20(4):511-23
references.pmid: 22014576
references.citation: Surg Oncol. 2009 Dec;18(4):357-65
references.pmid: 19027288
references.citation: Clin Exp Metastasis. 2012 Jun;29(5):457-69
references.pmid: 22407310
references.citation: PLoS Biol. 2011 Apr;9(4):e1001046
references.pmid: 21526222
references.citation: Ann Oncol. 1998 Feb;9(2):159-65
references.pmid: 9553660
references.citation: J Cell Sci. 2012 Mar 1;125(Pt 5):1284-95
references.pmid: 22302998
references.citation: Oncogene. 2012 Nov 8;31(45):4768-77
references.pmid: 22249257
references.citation: Exp Biol Med (Maywood). 2012 Apr;237(4):362-71
references.pmid: 22490514
references.citation: Cancer Res. 2011 Aug 1;71(15):5081-9
references.pmid: 21676886
references.citation: Cancer Res. 2011 Jan 15;71(2):550-60
references.pmid: 21098088
references.citation: J Neuroinflammation. 2012 Sep 06;9:211
references.pmid: 22950459
references.citation: Nat Cell Biol. 2009 Mar;11(3):228-34
references.pmid: 19255566
references.citation: Int J Oncol. 2009 Jul;35(1):109-14
references.pmid: 19513557
references.citation: Cell Cycle. 2012 Jan 1;11(1):177-86
references.pmid: 22185756
references.citation: Blood. 2012 Dec 20;120(26):5188-98
references.pmid: 23077289
references.citation: J Biol Chem. 2010 Nov 5;285(45):34447-59
references.pmid: 20805228
references.citation: Nat Rev Cancer. 2012 Jul 19;12(8):564-71
references.pmid: 22810811
references.citation: Blood. 2011 Dec 15;118(25):6572-9
references.pmid: 22039262